The Effect of Using Coconut Oil and Moisturizing Lotion in Moisturizing the Skin of Premature Newborns

NCT07503457 | Completed

• 1 other identifier: Aydın Adnan Menderes Uni
• Study Type: interventional
• Target: 90
• Locations: 1 country
• Sites: 1

Brief Summary

Hypothesis H01: Using coconut oil and moisturizing lotion to moisturize the skin of preterm infants has no effect on skin condition assessment scores. Hypothesis H02: Using coconut oil and moisturizing lotion to moisturize the skin of preterm infants has no effect on pH values. Hypothesis H03: Using coconut oil and moisturizing lotion to moisturize the skin of preterm infants has no effect on skin moisture levels. Hypothesis H04: Using coconut oil and moisturizing lotion to moisturize the skin of preterm infants has no effect on body temperature values. Hypothesis H05: Using coconut oil and moisturizing lotion to moisturize the skin of preterm infants has no effect on pulse values. Hypothesis H06: Using coconut oil and moisturizing lotion to moisturize the skin of preterm infants has no effect on saturation values.

Conditions

Child

Keywords

moisturizing lotion; coconut oil; Preterm

Outcome Measures

Primary Outcomes (2)

• Infant Information and Monitoring Form (Appendix 1):

  The Infant Information Form is an 8-question form prepared by researchers using literature. The form includes information on the baby's demographic characteristics, gender, gestational age at birth and corrected gestational age, mode of delivery, birth weight, head circumference, medical diagnosis, and feeding type. Additionally, a table is included at the bottom of the form for recording the baby's body temperature, heart rate, oxygen saturation, skin moisture, and skin pH before and for 5 days after the procedure.

  five days

• Neonatal Skin Status Assessment (Appendix 2):

  This scale, developed by Lund and Osborne (2004), is used to assess the skin status of healthy or sick preterm, term, and postterm newborns. The newborn's skin status is scored based on the presence of redness, dryness, and impaired skin integrity/peeling. It is developed as a three-point Likert scale, with each item/finding given a score from 1 to 3. The lowest possible score is 3, and the highest is 9. A total score higher than 3 indicates a risk of impaired skin integrity in the newborn, while a higher score indicates poor skin status. The reliability of the scale has been reported by researchers to be between 0.66 and 0.89.

  five days

Study Arms (2)

Moisturizing Lotion

EXPERIMENTAL

* Intervention Group 1 (Moisturizing Lotion) * The application and data collection will be carried out by Nurse Zehra SÖZKESEN, who works in the neonatal intensive care unit where the research will be conducted. The research will last 5 days for each baby. Measurements will be taken before and after the application (15 minutes after application). * Before the application, the parent will be consulted and an "Informed Consent Form" will be completed. * Applications will be performed in a way that does not disrupt the ward routine and will be carried out after daily care during routine care hours, between 09:00-10:00 in the morning. * The lotion to be used for babies included in the moisturizing lotion group will be kept at the patient's bedside with a barcode label attached to each patient, and a separate sterile container of lotion will be used for each patient. * Before the application, the researcher will wash their hands according to the hospital's procedur

Behavioral: Moisturizing Lotion

Coconut Oil Group

EXPERIMENTAL

Intervention Group 2 (Coconut Oil Group) * The application and data collection will be carried out by Nurse Zehra SÖZKESEN, who works in the neonatal intensive care unit where the research will be conducted. The research will last 5 days for each baby. Measurements will be taken before and after the application (15 minutes after the application). * Before the application, the parent will be consulted and an "Informed Consent Form" will be completed. * Applications will be performed in a way that does not disrupt the ward routine and will be carried out after daily care between 09:00-10:00 in the morning, which are routine care hours. * The oil to be used for babies included in the coconut oil group will be kept at the patient's bedside with a barcode label attached to each patient and will be used in a separate sterile container for each patient. * Before the application, the researcher will wash their hands according to the hospital's procedure.

Behavioral: Oil Application

Interventions

Oil Application BEHAVIORAL

* The researcher will wash their hands again according to the hospital's procedure. * During the application, the baby will first be placed on its back, then on its side and stomach, and the body will be lubricated with coconut oil. * Coconut oil will be applied to the entire body surface except the hands, head, face, and genital area with light touches using the palm of the hand. The application will take approximately 8-10 minutes. The amount of oil to be used in each application will be approximately 3-4 ml/kg.

Coconut Oil Group

Moisturizing Lotion BEHAVIORAL

The researcher will wash their hands again according to the hospital's procedure. During the application, the baby will first be placed on its back, then on its side and stomach, and the body will be lubricated with moisturizing lotion. Moisturizing Lotion will be applied to the entire body surface except the hands, head, face, and genital area with light touches using the palm of the hand. The application will take approximately 8-10 minutes. The amount of oil to be used in each application will be approximately 3-4 ml/kg.

Moisturizing Lotion

Eligibility Criteria

• Age: 32 Weeks - 37 Weeks
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17)

You may qualify if:

• Babies with a gestational age between 320/7 and 376/7 weeks,
• Babies with a birth weight of 1500 grams or more will be included.

You may not qualify if:

• are receiving oxygen support at a concentration greater than 23-25% in the incubator,
• have a major congenital anomaly on the skin surface,
• have a high infection or risk of infection due to surgery,
• have a congenital anomaly,
• have a skin disease/problem covering more than 5% of their body surface will not be included.

Sponsors & Collaborators

• Bircan Kahraman Berberoglu: lead
• Aydin Adnan Menderes University: collaborator

Study Sites (1)

Adnan Menderes Univercity

Aydin, Aydın, Turkey (Türkiye)

Location

Related Links

• Related Info

MeSH Terms

Conditions

Premature Birth

Condition Hierarchy (Ancestors)

Obstetric Labor, Premature; Obstetric Labor Complications; Pregnancy Complications; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: doctor

Study Record Dates

• First Submitted: March 26, 2026
• First Posted: March 31, 2026
• Study Start: March 16, 2024
• Primary Completion: March 16, 2025
• Study Completion: September 16, 2025
• Last Updated: April 27, 2026

Record last verified: 2026-04

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)